$1.84
0.05212.91%
Last update: Nov 11, 4:56 PM
SILO Pharma Inc
SILONASDAQ
SILO Pharma fell 73.6% from $6.98 to $1.84, behind the S&P 500's +9.8%. Its worst day was Jul 10 (−26.3%), and its low came Oct 19 at $1.13.
Nov 11, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-1.80 was reported on $18,025.00 revenue.
−5.2% · S&P 500 0.0%
SILO Pharma shares rose 24.0%, while the S&P 500 rose 0.7%.
+24.0% · S&P 500 +0.7%
Story events cover the past 12 months · Times ET
EPS of $-0.98 was reported on $18,026.00 revenue.
+0.8% · S&P 500 −0.3%
EPO Greenlights Claims Covering Preventative use of therapy targeting 5-HT4 Pathway and Expands Silo Pharma IP PortfolioSARASOTA, FL, April 06, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc.
+49.0%, the year's best day, on 11M shares, the year's heaviest volume · S&P 500 0.0%
SILO Pharma closed at its highest level of the year, 43.2% above where the year started.
+29.3% · S&P 500 −0.2%
EPS of $-1.80 was reported on $18,026.00 revenue.
+1.6% · S&P 500 −1.2%
SILO Pharma shares fell 22.3%, while the S&P 500 rose 0.3%.
−22.3% · S&P 500 +0.3%
SILO Pharma shares fell 26.3%, while the S&P 500 rose 0.4%.
−26.3%, the year's worst day · S&P 500 +0.4%
EPS of $-0.76 was reported on $0.00 revenue.
−0.6% · S&P 500 −0.2%
SILO Pharma closed at its lowest level of the year, 83.8% below where the year started.
−4.2% · S&P 500 +0.4%
Where it ended: a close of $1.84 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 24, 2026.
Nothing in the past 12 months.
All SILO analyst actionsNothing in the past 12 months.
All SILO dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SILO and SPY from Benzinga historical bars. Not investment advice.
